Effects of vancomycin, daptomycin, and tigecycline on coagulase-negative staphylococcus biofilm and bacterial viability within biofilm: an in vitro biofilm model.
Bacteria may hide in a hydrated polysaccharide matrix known as a biofilm. The structure of the bacterial biofilm renders phagocytosis difficult and increases antibiotic resistance. We hypothesized that repeated doses of antibiotics have an effect on bacteria within the biofilm and that it could inhibit or eradicate biofilm formation. Two clinical biofilm-positive coagulase-negative staphylococcus isolates were evaluated. The effects of antibiotics on preformed and nascent biofilm and on bacterial eradication within the biofilm were determined using different doses of vancomycin, daptomycin, and tigecycline for different durations in an in vitro biofilm model. Vancomycin neither penetrated the biofilm nor had any microbicidal effect on bacteria within the biofilm. Daptomycin had a microbicidal effect on bacteria within the biofilm but had no effect on biofilm inhibition and eradication (independent from dose and treatment time). Tigecycline inhibited and eradicated biofilm formation and had a microbicidal effect on bacteria within the biofilm. In conclusion, (i) biofilm formation appeared to be a major barrier to vancomycin activity, (ii) daptomycin had an antimicrobial effect on the bacteria within the biofilm but not on the biofilm burden, and (iii) tigecycline had effects both on bacteria within the biofilm and on biofilm burden. Thus, both tigecycline and daptomycin might be promising candidates for the treatment of biofilm infections.
a Department of Infectious Diseases and Clinical Microbiology, School of Medicine, University of Adnan Menderes, 09010 Aydin, Turkey.
Barcin
B
Ozturk
b ADUBILTEM Research and Development Center, University of Adnan Menderes, 09010 Aydin, Turkey.
Necati
N
Gunay
a Department of Infectious Diseases and Clinical Microbiology, School of Medicine, University of Adnan Menderes, 09010 Aydin, Turkey.
Bulent M
BM
Ertugrul
a Department of Infectious Diseases and Clinical Microbiology, School of Medicine, University of Adnan Menderes, 09010 Aydin, Turkey.
Serhan
S
Sakarya
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D018441:Biofilms / Q000187:drug effects; D003030:Coagulase / Q000378:metabolism; D017576:Daptomycin / Q000494:pharmacology*; D050296:Microbial Viability / Q000187:drug effects; D008911:Minocycline / Q000031:analogs & derivatives* / Q000494:pharmacology; D008954:Models, Biological; D013210:Staphylococcus / Q000187:drug effects* / Q000201:enzymology; D000078304:Tigecycline; D014640:Vancomycin / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D003030:Coagulase; D014640:Vancomycin; D000078304:Tigecycline; D008911:Minocycline; D017576:Daptomycin
biofilm; daptomycin; daptomycine; tigecycline; tigécycline; vancomycin; vancomycine